When did Tango Therapeutics report Q4 2024 earnings?

Tango Therapeutics (TNGX) reported Q4 2024 earnings on February 27, 2025 before market open.

What were Tango Therapeutics's Q4 2024 revenue and EPS?

Tango Therapeutics reported revenue of $4.1M and eps of $-0.35 for Q4 2024.

Did Tango Therapeutics beat estimates in Q4 2024?

Revenue missed the consensus estimate of $8.0M by $3.9M. EPS missed the consensus estimate of $-0.32 by $0.03.

Where can I find Tango Therapeutics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-028353) directly on SEC EDGAR. The filing index links above go to sec.gov.

Tango Therapeutics TNGX Q4 2024 Annual earnings

Reported February 27, 2025 · Before market open

Revenue$4.1MMiss by $3.9M

EPS-$0.35Miss by $0.03

Revenue estimate$8.0M

EPS estimate-$0.32

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$1.6M

EPS estimate-$0.31

Financials

Q4 2024

Income statement

See full

Revenue$4.1M-24.2%

Operating income-$40.9M-16.8%

Net income-$37.7M-22.5%

EPS (diluted)-$0.34-13.3%

Balance sheet

See full

Cash & equivalents$69.5M+4.7%

Total debt$36.5M0.0%

Total equity$199.5M-21.2%

Total assets$316.5M-21.4%

Cash flow

See full

Operating cash flow-$36.6M-33.4%

CapEx$124.0K-45.1%

Free cash flow-$36.8M-32.8%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$331.92M-65.5%

Enterprise value$298.88M-68.0%

P/S7.9×-18.5×

Profitability

See full

Operating margin-346.1%+41.6pp

Net margin-309.7%+39.0pp

FCF margin-314.4%-11.8pp

Returns & leverage

See full

Return on equity-57.6%+42.0pp

Debt / equity0.2×0.0×

Current ratio7×-0.6×

Versus estimates

Revenue

Q3 2025$53.8MBeat by $53.3M Q2 2025$3.2MMiss by $3.2M Q1 2025$5.4MMiss by $967.3K

Q4 2024$4.1MMiss by $3.9M

Diluted EPS

Q1 2026-$0.32In line Q4 2025-$0.29Beat by $0.02 Q3 2025$0.13Beat by $0.12 Q2 2025-$0.35In line Q1 2025-$0.36Miss by $0.02

Q4 2024-$0.35Miss by $0.03

Ask the moment Tango Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Tango Therapeutics report Q4 2024 earnings?: Tango Therapeutics (TNGX) reported Q4 2024 earnings on February 27, 2025 before market open.
What were Tango Therapeutics's Q4 2024 revenue and EPS?: Tango Therapeutics reported revenue of $4.1M and eps of $-0.35 for Q4 2024.
Did Tango Therapeutics beat estimates in Q4 2024?: Revenue missed the consensus estimate of $8.0M by $3.9M. EPS missed the consensus estimate of $-0.32 by $0.03.
Where can I find Tango Therapeutics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-028353) directly on SEC EDGAR. The filing index links above go to sec.gov.